Prime Health to Provide Access to MDxHealth's Prostate Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth today said that it has signed an agreement with preferred provider organization Prime Health Services to offer its ConfirmMDx for Prostate Cancer test to Prime Health's members.

MDxHealth said the agreement covers all 50 states and extends ConfirmMDx's testing to around 144 million covered lives throughout the US. Prime Health serves more than 700,000 providers and facilities nationwide through its Prime Health Delivery System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.